Bank of New York Mellon’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $46.2M | Sell |
|
|||||
2024
Q4 | $30M | Buy |
|
|||||
2024
Q3 | $25.7M | Buy |
|
|||||
2024
Q2 | $23.9M | Sell |
|
|||||
2024
Q1 | $26M | Sell |
|
|||||
2023
Q4 | $29.7M | Buy |
|
|||||
2023
Q3 | $21.1M | Buy |
|
|||||
2023
Q2 | $25.2M | Buy |
|
|||||
2023
Q1 | $21M | Sell |
|
|||||
2022
Q4 | $20.6M | Buy |
|
|||||
2022
Q3 | $18.1M | Buy |
|
|||||
2022
Q2 | $21.9M | Sell |
|
|||||
2022
Q1 | $23.6M | Buy |
|
|||||
2021
Q4 | $19.2M | Buy |
|
|||||
2021
Q3 | $12.9M | Buy |
|
|||||
2021
Q2 | $13.5M | Buy |
|
|||||
2021
Q1 | $10.3M | Buy |
|
|||||
2020
Q4 | $9.29M | Sell |
|
|||||
2020
Q3 | $7.99M | Buy |
|
|||||
2020
Q2 | $6.42M | Buy |
|
|||||
2020
Q1 | $3.57M | Buy |
|
|||||
2019
Q4 | $6.48M | Sell |
|
|||||
2019
Q3 | $1.42M | Sell |
|
|||||
2019
Q2 | $2.67M | Sell |
|
|||||
2019
Q1 | $2.62M | Buy |
|
|||||
2018
Q4 | $2.39M | Buy |
|
|||||
2018
Q3 | $4.5M | Buy |
|
|||||
2018
Q2 | $3.65M | Sell |
|
|||||
2018
Q1 | $4.39M | Sell |
|
|||||
2017
Q4 | $3.11M | Buy |
|
|||||
2017
Q3 | $2.67M | Sell |
|
|||||
2017
Q2 | $2.13M | Buy |
|
|||||
2017
Q1 | $2.39M | Sell |
|
|||||
2016
Q4 | $2.23M | Sell |
|
|||||
2016
Q3 | $2.41M | Sell |
|
|||||
2016
Q2 | $6.88M | Buy |
|
|||||
2016
Q1 | $4.14M | Sell |
|
|||||
2015
Q4 | $9.04M | Buy |
|
|||||
2015
Q3 | $5.43M | Sell |
|
|||||
2015
Q2 | $4.84M | Buy |
|
|||||
2015
Q1 | $2.41M | Buy |
|
|||||
2014
Q4 | $1.5M | Sell |
|
|||||
2014
Q3 | $1.19M | Buy |
|
|||||
2014
Q2 | $1.24M | Buy |
|